Published Online
on July 13, 2009

A more recent version of this article appeared on September 1, 2009

This Article Full Text (PDF) All Versions of this Article: 54/3/473    most recent HYPERTENSIONAHA.109.135251v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Chicoine, L. G. Articles by Lucchesi, P. A. PubMed PubMed Citation Articles by Chicoine, L. G. Articles by Lucchesi, P. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB MONOCROTALINE Medline Plus Health Information Pulmonary Hypertension Related Collections Remodeling Primary prevention Animal models of human disease Smooth muscle proliferation and differentiation Pulmonary circulation and disease Oxidant stress Related Article

Is Resveratrol the Magic Bullet for Pulmonary Hypertension?

Louis G. Chicoine; James A. Stewart Jr; and Pamela A. Lucchesi^*

From the Center for Gene Therapy (L.G.C.), Center for Cardiovascular and Pulmonary Research (J.A.S., P.A.L.), and the Heart Center (J.A.S., P.A.L.), Nationwide Children's Hospital, Columbus, Ohio.

^* To whom correspondence should be addressed. E-mail: Pamela.Lucchesi{at}nationwidechildrens.org.

Related Article:

Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats

Anna Csiszar, Nazar Labinskyy, Susan Olson, John T. Pinto, Sachin Gupte, Joseph M. Wu, Furong Hu, Praveen Ballabh, Andrej Podlutsky, Gyorgy Losonczy, Rafael de Cabo, Rajamma Mathew, Michael S. Wolin, and Zoltan Ungvari
Hypertension 2009 54: 668-675. [Abstract] [Full Text] [PDF]